RSS feed
Consultation
We ask for feedback on proposals through public consultation, and take all consultation responses we receive into account before making our decisions.
We welcome feedback from pharmaceutical suppliers, health professionals, health interest groups and the general public. This page includes consultations that are currently underway.
You can respond to consultation by writing to the address at the bottom of the consultation letter.
Rapid response
If you would like to make a rapid response to any of our consultations, 
click here. Remember to indicate which consultation proposal your comments relate to.
- Extension to consultation on fentanyl patch proposal (1 page, 159 KB) 06 May 2008
- Proposal for 12 months trastuzumab (Herceptin) treatment (4 pages, 222 KB) 05 May 2008
- Consultation on recombinant factor VIII provisional agreements (3 pages, 179 KB) 02 May 2008
- Proposal to widen access to fentanyl transdermal patches under a sole supply arrangement (3 pages, 59 KB) 23 Apr 2008
- Proposal to amend pharmaceuticals restrictions on alimentary tract and metabolism (4 pages, 175 KB) 22 Apr 2008
Page updated on 06 May 2008
Linked documents
Extension to consultation on fentanyl patch proposal (1 page, 159 KB)
6 May 2008 CONSULTATION ON PROPOSAL TO WIDEN ACCESS TO FENTANYL PATCHES – EXTENSION TO RESPONSE DEADLINE PHARMAC has received requests to extend the deadline for responses to consultation on a proposal to widen access to fentanyl transdermal patches (consultation…
Proposal for 12 months trastuzumab (Herceptin) treatment (4 pages, 222 KB)
Recently the High Court ruled on a Judicial Review of PHARMAC’s processes surrounding its decisions to fund a…
Consultation on recombinant factor VIII provisional agreements (3 pages, 179 KB)
PHARMAC is seeking feedback on three proposals to amend the listing of recombinant factor VIII in the Pharmaceutical Schedule from 1 July…
Proposal to widen access to fentanyl transdermal patches under a sole supply arrangement (3 pages, 59 KB)
The opioid analgesic fentanyl, formulated as a transdermal patch, is currently subsidised (funded) only via Special Authority for patients who are terminally…
Proposal to amend pharmaceuticals restrictions on alimentary tract and metabolism (4 pages, 175 KB)
PHARMAC is seeking public feedback on a proposal to alter restrictions on 13 medicines. This letter outlines the proposal and how you can provide your feedback on…
